Top

Published in:

01-11-2003 | Breast

Invasive breast cancer: correlation of dynamic MR features with prognostic factors

Authors: Botond K. Szabó, Peter Aspelin, Maria Kristoffersen Wiberg, Tibor Tot, Beata Boné

Published in: European Radiology | Issue 11/2003

Abstract

The purpose of this exploratory study was to correlate kinetic and morphologic MR features with histologic prognostic factors in invasive breast cancer. Sixty-one women with invasive breast cancer underwent dynamic contrast-enhanced MR imaging at 1.5 T, using T1-weighted 3D fast low-angle shot technique. The MR characteristics were correlated with classical pathologic prognostic factors (tumor size, histologic type, grade and lymph node status) and immunohistochemically detected biomarkers [c-erbB-2, p53, Ki-67, and estrogen receptor (ER)]. Univariate and multivariate statistical analyses were performed. Presence of rim enhancement pattern, early maximal enhancement and washout phenomenon were independently associated with established predictors of poor prognosis (higher histologic grade, positive Ki-67, and negative ER status). Our results suggest that these MR signs are not only important in differentiating benign from malignant lesions, but may also be useful to noninvasively identify highly aggressive breast carcinomas.

Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13–30CrossRef

Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP (1999) Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 6:387–397CrossRef

Boetes C, Barentsz JO, Mus RD et al. (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777–781CrossRef

Orel SG, Schnall MD, LiVolsi VA, Troupin RH (1994) Suspicious breast lesions: MR imaging with radiologic–pathologic correlation. Radiology 190:485–493CrossRef

Kuhl CK, Mielcareck P, Klaschik S et al. (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110CrossRef

Abraham DC, Jones RC, Jones SE et al. (1996) Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78:91–100CrossRef

Boné B, Aspelin P, Bronge L, Veress B (1998) Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 39:279–284CrossRef

Mussurakis S, Buckley DL, Horsman A (1997) Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 70:446–451CrossRef

Stomper PC, Herman S, Klippenstein DL et al. (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197:387–395CrossRef

10.

Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E (1997) Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 7:1002–1005CrossRef

11.

Elston CW, Ellis IO, Pinder SE (1999) Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 31:209–223CrossRef

12.

Yaghan R, Stanton PD, Robertson KW, Going JJ, Murray GD, McArdle CS (1998) Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol 24:424–426CrossRef

13.

Lovekin C, Ellis IO, Locker A et al. (1991) c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439–443CrossRef

14.

Bergh J (1999) Clinical studies of p53 in treatment and benefit of breast cancer patients. Endocr Relat Cancer 6:51–59CrossRef

15.

Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322CrossRef

16.

Fox SB (1997) Tumour angiogenesis and prognosis. Histopathology 30:294–301CrossRef

17.

Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324:1–8CrossRef

18.

Gasparini G, Harris AL (1995) Clinical importance of determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13:765–782CrossRef

19.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S (1996) Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88:1764–1769CrossRef

20.

Axelsson K, Ljung BM, Moore DH II et al. (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 87:997–1008CrossRef

21.

Goulding H, Abdul-Rashid NF, Robertson JF et al. (1995) Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 26:1196–1200CrossRef

22.

Frouge C, Guinebretiere JM, Contesso G, Paola R di, Blery M (1994) Correlation between contrast-enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 29:1043–1049CrossRef

23.

Buadu LD, Murakami J, Murayama S et al. (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200:639–649CrossRef

24.

Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A (1997) Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 7:461–464CrossRef

25.

Nunes LW, Schnall MD, Orel SG et al. (1997) Breast MR imaging: interpretation model. Radiology 202:833–841CrossRef

26.

Schnall MD, Rosten S, Englander S, Orel SG, Nunes LW (2001) A combined architectural and kinetic interpretation model for breast MR images. Acad Radiol 8:591–597CrossRef

27.

Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681–686CrossRef

28.

Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W (1989) MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 171:95–103CrossRef

29.

Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT (1990) Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174:491–494CrossRef

30.

Heywang-Köbrunner SH, Bick U, Bradley WG Jr et al. (2001) International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11:531–546CrossRef

31.

Ikeda O, Yamashita Y, Morishita S et al. (1999) Characterization of breast masses by dynamic-enhanced MR imaging: a logistic regression analysis. Acta Radiol 40:585–592CrossRef

32.

Elston CW (1987) Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast, 1st edn. Churchill Livingstone, Edinburgh, pp 300–311

33.

Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999) Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17:2334–2340CrossRef

34.

Mirza AN, Mirza NQ, Vlastos G, Singletary SE (2002) Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 235:10–26CrossRef

35.

Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180CrossRef

36.

Jong J, van Diest P, Baak JP (1995) Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 73:922–926PubMed

37.

Ahlgren J, Risberg B, Villman K, Bergh J (2002) Angiogenesis in invasive breast carcinoma: a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69CrossRef

38.

Gasparini G (2000) Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5 (Suppl 1):37–44CrossRef

39.

Hulka CA, Edmister WB, Smith BL et al. (1997) Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205:837–842CrossRef

40.

Helbich TH, Roberts TP, Gossmann A et al. (2000) Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magn Reson Med 44:915–924CrossRef

41.

Knopp MV, Weiss E, Sinn HP et al. (1999) Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10:260–266CrossRef

42.

Wedegartner U, Bick U, Wortler K, Rummeny E, Bongartz G (2001) Differentiation between benign and malignant findings on MR mammography: usefulness of morphological criteria. Eur Radiol 11:1645–1650CrossRef

43.

Mussurakis S, Buckley DL, Drew PJ et al. (1997) Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clin Radiol 52:516–526CrossRef

44.

Schnall MD (2001) An overview of interpretation strategies for breast MR imaging. Magn Reson Imaging Clin N Am 9:289–294PubMed

45.

Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S (2000) Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 217:841–848CrossRef

46.

Stomper PC, Herman S, Klippenstein DL, Winston JS, Budnick RM, Stewart CC (1996) Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer 77:1844–1849CrossRef

47.

Sherif H, Mahfouz AE, Oellinger H et al. (1997) Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 205:209–213CrossRef

48.

Linderholm B, Tavelin B, Grankvist K, Henriksson R (1998) Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 16:3121–3128CrossRef

49.

Kumar R, Yarmand-Bagheri R (2001) The role of HER2 in angiogenesis. Semin Oncol 28(Suppl 16):27–32CrossRef

50.

Izumi Y, Xu L, Tomaso E di, Fukumura D, Jain RK (2002) Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature 416:279–280CrossRef

51.

Nakopoulou L, Stefanaki K, Panayotopoulou E et al. (2002) Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation. Hum Pathol 33:863–870CrossRef

52.

Bone B, Wiberg MK, Parrado C, Falkmer U, Aspelin P, Gad A (1998) Mechanism of contrast enhancement in breast lesions at MR imaging. Acta Radiol 39:494–500CrossRef

Title: Invasive breast cancer: correlation of dynamic MR features with prognostic factors
Authors: Botond K. Szabó
Peter Aspelin
Maria Kristoffersen Wiberg
Tibor Tot
Beata Boné
Publication date: 01-11-2003
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 11/2003
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-003-2000-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Invasive breast cancer: correlation of dynamic MR features with prognostic factors

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2003

Multidetector-row computed tomography of the coronary arteries: predictive value and quantitative assessment of non-calcified vessel-wall changes

Sarcoidosis: assessment of disease severity using HRCT

Radio-frequency thermal ablation with hypertonic saline solution injection of the lung: ex vivo and in vivo feasibility studies

Unenhanced helical computed tomography vs intravenous urography in patients with acute flank pain: accuracy and economic impact in a randomized prospective trial

Performance of Web-based image distribution: server-oriented measurements

Covered stenting in patients with lifting of gastric and high esophago-tracheal fistula